Skip to main content
Donate

Moments of Hope

A collection of hope by parents and caregivers.

Read inspiring moments shared by the community of a distinct experience with their loved one living with AS that gave them hope and energy to fight for a cure.

FAST Angelman Syndrome News

FAST × ASA Angelman Syndrome Clinical Trials Webinar: Europe/UK Sites, Eligibility, and How to Join Trials

If Will CAN, We CAN: A Family’s Vision to #KickAS in Minneapolis

How Harper’s Hope Golf Tournament Has Raised Over $350,000 for Angelman Syndrome Research

MavriX Bio MVX-220 Update

Reading the brain’s signals to speed better treatments for Angelman syndrome

Joe Bologna Charity Golf Outing Raises $36,000 for Sutton Strong and Angelman Syndrome Research

Ionis Receives Breakthrough Therapy Designation for ION582 in Angelman Syndrome

FAST-Funded Project Introduces First Large Animal Model to Study Angelman Syndrome

FAST Global: Cure Angelman Now Fundraising Efforts

CAN Spotlight: Honoring “Hendu” with Hope and Research: The Always Having Fun Foundation’s Golf Classic

Turning Possibility Into Progress: The Rush F.A.S.T. Center for Translational Research Opens in Chicago

CAN Spotlight: Payslie’s Pals Cornhole Tournament Brings Community Together for FAST Research

Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelma...

The LaMuras organized Rally for a Cure, a Tennis-Themed Event that Brought Together Their Community

Inside INSYNC-AS 2025: Progress, Partnership, and Possibilities for Angelman Syndrome

Charlie's Angels Chari-Tee Golf Tournament: A Day of Hope, Community, and Action

Oak Hill Bio Announces Publication of Rugonersen Phase 1 Study Results in Nature Medicine

Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome

Investing in the Future of Angelman Syndrome Research: FAST Partners with ASGCT to Support Early-Career...

First patient dosed in pivotal Phase 3 REVEAL clinical study of ION582 in Angelman syndrome

FAST × ASA Angelman Syndrome Clinical Trials Webinar: Europe/UK Sites, Eligibility, and How to Join Trials

If Will CAN, We CAN: A Family’s Vision to #KickAS in Minneapolis

How Harper’s Hope Golf Tournament Has Raised Over $350,000 for Angelman Syndrome Research

MavriX Bio MVX-220 Update

Reading the brain’s signals to speed better treatments for Angelman syndrome

Joe Bologna Charity Golf Outing Raises $36,000 for Sutton Strong and Angelman Syndrome Research

Ionis Receives Breakthrough Therapy Designation for ION582 in Angelman Syndrome

FAST-Funded Project Introduces First Large Animal Model to Study Angelman Syndrome

FAST Global: Cure Angelman Now Fundraising Efforts

CAN Spotlight: Honoring “Hendu” with Hope and Research: The Always Having Fun Foundation’s Golf Classic

Turning Possibility Into Progress: The Rush F.A.S.T. Center for Translational Research Opens in Chicago

CAN Spotlight: Payslie’s Pals Cornhole Tournament Brings Community Together for FAST Research

Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelma...

The LaMuras organized Rally for a Cure, a Tennis-Themed Event that Brought Together Their Community

Inside INSYNC-AS 2025: Progress, Partnership, and Possibilities for Angelman Syndrome

Charlie's Angels Chari-Tee Golf Tournament: A Day of Hope, Community, and Action

Oak Hill Bio Announces Publication of Rugonersen Phase 1 Study Results in Nature Medicine

Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome

Investing in the Future of Angelman Syndrome Research: FAST Partners with ASGCT to Support Early-Career...

First patient dosed in pivotal Phase 3 REVEAL clinical study of ION582 in Angelman syndrome

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.